CH624929A5 - - Google Patents

Download PDF

Info

Publication number
CH624929A5
CH624929A5 CH166376A CH166376A CH624929A5 CH 624929 A5 CH624929 A5 CH 624929A5 CH 166376 A CH166376 A CH 166376A CH 166376 A CH166376 A CH 166376A CH 624929 A5 CH624929 A5 CH 624929A5
Authority
CH
Switzerland
Prior art keywords
methyl
radical
compounds
hydrogen
formula
Prior art date
Application number
CH166376A
Other languages
German (de)
English (en)
Inventor
Udo Friedrich Axen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CH624929A5 publication Critical patent/CH624929A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/19—Acids containing three or more carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/19—Acids containing three or more carbon atoms
    • C07C53/21—Acids containing three or more carbon atoms containing fluorine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4015—Esters of acyclic unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH166376A 1975-02-24 1976-02-11 CH624929A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/552,708 US4001300A (en) 1975-02-24 1975-02-24 2,2-Difluoro-16-phenoxy-PGF2 analogs

Publications (1)

Publication Number Publication Date
CH624929A5 true CH624929A5 (fr) 1981-08-31

Family

ID=24206453

Family Applications (1)

Application Number Title Priority Date Filing Date
CH166376A CH624929A5 (fr) 1975-02-24 1976-02-11

Country Status (11)

Country Link
US (7) US4001300A (fr)
JP (1) JPS6032624B2 (fr)
BE (1) BE838878A (fr)
CH (1) CH624929A5 (fr)
DE (1) DE2606051A1 (fr)
FR (2) FR2301241A1 (fr)
GB (1) GB1494588A (fr)
HU (1) HU177770B (fr)
NL (1) NL7601795A (fr)
SE (1) SE7601566L (fr)
ZA (1) ZA76512B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2655004C3 (de) * 1976-12-02 1980-06-19 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von bicyclischen Laktonen
US4929740A (en) * 1984-10-09 1990-05-29 Syntex (U.S.A.) Inc. Process for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives
US4778904A (en) * 1985-09-13 1988-10-18 Syntex (U.S.A.) Inc. Intermediates for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives
JP2721414B2 (ja) * 1988-09-06 1998-03-04 フアーマシア・アンド・アツプジヨン・アー・ベー 縁内障または眼圧亢進の治療のためのプロスタグランジン誘導体
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531514A (en) * 1966-09-26 1970-09-29 Petrolite Corp Phosphonium compounds and/or ethylene glycol - bis-(trialkylphosphonium acetates)
US3736349A (en) * 1968-08-19 1973-05-29 American Cyanamid Co Flame-retardant agents for thermoplastic products
BR6915068D0 (pt) * 1969-03-14 1973-05-24 Upjohn Co Processo de producao de derivados racemicos de prostaglandina
GB1282663A (en) * 1969-03-14 1972-07-19 Upjohn Co Bicyclo[3,1,0]hexan-3-one derivatives and the manufacture thereof
US3728382A (en) * 1970-05-04 1973-04-17 Upjohn Co 15-methyl and 15-ethyl prostaglandin analogs
US3775462A (en) * 1971-02-02 1973-11-27 Upjohn Co Racemic pge3
US3847967A (en) * 1971-05-04 1974-11-12 F Lincoln 15-lower alkoxy pgb compounds
US3919286A (en) * 1972-09-13 1975-11-11 Upjohn Co Prostaglandin A{HD 2 {B analogs
US3962293A (en) * 1973-07-20 1976-06-08 The Upjohn Company 13,14-Dihydro-16-fluoro prostaglandin F1

Also Published As

Publication number Publication date
DE2606051A1 (de) 1976-09-02
US4065633A (en) 1977-12-27
HU177770B (en) 1981-12-28
FR2301241A1 (fr) 1976-09-17
US4068083A (en) 1978-01-10
NL7601795A (nl) 1976-08-26
US4073803A (en) 1978-02-14
JPS51113855A (en) 1976-10-07
US4057574A (en) 1977-11-08
ZA76512B (en) 1977-01-26
AU1068976A (en) 1977-08-04
SE7601566L (sv) 1976-08-25
US4097519A (en) 1978-06-27
FR2320303B3 (fr) 1979-07-27
US4001300A (en) 1977-01-04
FR2301241B1 (fr) 1982-11-19
FR2320303A1 (fr) 1977-03-04
JPS6032624B2 (ja) 1985-07-29
BE838878A (fr) 1976-08-24
GB1494588A (en) 1977-12-07
US4064160A (en) 1977-12-20

Similar Documents

Publication Publication Date Title
DE2322673A1 (de) Neue verbindungen vom prostaglandintyp und verfahren zu ihrer herstellung
CH628028A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14.
DE2423155A1 (de) 5-oxa-prostaglandine und verfahren zu deren herstellung
CH626876A5 (fr)
DE2317019A1 (de) Neue 4,5-didehydro-prostaglandine
DE2355731A1 (de) Neue 15-substituierte-omega-pentanorprostaglandine
CH625797A5 (fr)
US4013695A (en) 4,4,5,5-Tetradehydro-PGE1 analogs
DE2658207A1 (de) Prostaglandinanaloga und verfahren zu deren herstellung
DE2638827A1 (de) Neue 11-deoxy-prostaglandine e, f tief alpha und f tief beta
DE2659216A1 (de) Prostaglandin-analoga
CH624929A5 (fr)
DE2610718A1 (de) Neue 16-phenoxy-prostaglandin-verbindungen
CH634831A5 (en) Process for the preparation of optically active or racemic prostaglandins.
CH642063A5 (de) Verfahren zur herstellung von prostaglandin-analoga, bei welchen die carbonylgruppe am c-9 durch eine methylengruppe ersetzt ist.
JPS5938235B2 (ja) 中間体化合物の製法
CH617186A5 (fr)
CH630898A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14.
JPS6049632B2 (ja) １６−フェノキシ プロスタ グランジン類似体
CH623570A5 (fr)
CH630897A5 (en) Process for preparing novel prostaglandin analogues having a triple bond between C-13 and C-14.
DE2542686A1 (de) 2a,2b-dihomo-15-methyl- und -15- aethyl-pgf-und pge-verbindungen und verfahren zu deren herstellung
DE2716075A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan-analoga
CH630352A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14.
DE2355042A1 (de) Neue prostaglandinanaloge und verfahren zu deren herstellung

Legal Events

Date Code Title Description
PL Patent ceased